Enviral Tech, a Eugene, Ore.-based biotechnology company focused on environmental viral surveillance solutions including COVID surface testing, closed a $1.5M seed funding round.
The round was led by Oregon technology and healthcare venture capital fund, Rogue Venture Partners, with additional investments from Cascade Seed Fund and private investors.
The company intends to use the funds to continue to expand its business reach among the long-term care facilities, schools, and business marketplaces and increase research and development for the next generation of environmental viral detection solutions.
Founded in March 2020 by Dr. Shula Jaron, CEO, Enviral Tech is a biotechnology company focused on environmental viral building surveillance solutions. Its patented COVID surface testing and COVID air testing provide early coronavirus detection for the health of communities, by preventing new infections and improving business and consumer confidence. Enviral Tech has processed upwards of 20,000 coronavirus surface tests in more than 100 facilities nationwide.